According to a new clinical trial “chronic administration of CBD reduces ambulatory blood pressure in those with untreated and treated hypertension”.
The study was published in the recent issue of the peer-reviewed journal Cannabis and Cannabinoid Research, and it was published online ahead of print by the US National Library of Medicine.
“Recent data indicate that cannabidiol (CBD), a nonintoxicating constituent of cannabis, is involved in several aspects of cardiovascular regulation, including blood pressure (BP)”, begins the study’s abstract.
“However, the impact of chronic CBD administration on 24-h BP and vascular health has not been previously examined in patients with hypertension.”
Continue reading